688656.SH
浩欧博
SSE · Healthcare · Medical - Devices · CN
CNY 94.88
−6.78%Year over year
Reported trailing growth
- Revenue
- +1.3%
- EBITDA
- —
- EBIT
- -36.0%
- EPS
- -38.2%
- Free cash flow
- +334.9%
- Operating cash flow
- -24.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +7.5%
- EBITDA
- +6.0%
- EBIT
- -17.4%
- Net income
- -17.7%
- EPS
- -17.5%
- Free cash flow
- +98.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026